Global DNA methylation as a possible biomarker for diabetic retinopathy
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: We evaluated whether global levels of DNA methylation status were associated with retinopathy as well as providing a predictive role of DNA methylation in developing retinopathy in a case–control study of 168 patients with type 2 diabetes. Methods: The 5‐methylcytosine content was assessed by reversed‐phase high‐pressure liquid chromatography of peripheral blood leukocytes to determine an individual's global DNA methylation status in the two groups, either with or without retinopathy. Results: The global DNA methylation levels were significantly higher in diabetic retinopathy patients compared with those in non‐retinopathy patients (4.90 ± 0.12 vs. 4.22 ± 0.13, respectively;p = 0.001). There was a significant increasing trend in global DNA methylation levels in terms of progressing retinopathy (without retinopathy, 4.22 ± 0.13; non‐proliferative diabetic retinopathy, 4.62 ± 0.17; proliferative diabetic retinopathy, 5.07 ± 0.21) (p = 0.006). Additionally, global DNA methylation independent of retinopathy risk factors, which include dyslipidaemia, hypertension, hyperglycaemia and duration of diabetes, was a predictive factor for retinopathy (OR = 1.53,p = 0.015). Conclusions: Global DNA methylation is modulated during or possibly before the primary stage of diabetes. This observation verifies the metabolic memory effect of hyperglycaemia in early stage of an aetiological process that leads to type 2 diabetes and its associated complications. Copyright © 2014 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
(2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420603 · Cited by 1,534
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428 · cited 1×
“Epidemiological studies and clinical trials have demonstrated that retinopathy occurs in most diabetic patients despite subsequent interventions or metabolic successes [7,8,11,16,19,20].”
BackgroundEffect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Epigenetics: a molecular link between environmental factors and type 2 diabetes
Ling, C., & Groop, L. (2009) · Diabetes · doi:10.2337/db09-1003 · Cited by 617
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion
Ling, C., Del Guerra, S., Lupi, R., Rönn, T., Granhall, C., Luthman, H., Masiello, P., Marchetti, P., Groop, L., & Del Prato, S. (2008) · Diabetologia · doi:10.1007/s00125-007-0916-5 · Cited by 495
Progression of Incipient Diabetic Retinopathy During Good Glycemic Control
Engerman, R. L., & Kern, T. S. (1987) · Diabetes · doi:10.2337/diab.36.7.808 · Cited by 490 · cited 1×
“Epidemiological studies and clinical trials have demonstrated that retinopathy occurs in most diabetic patients despite subsequent interventions or metabolic successes [7,8,11,16,19,20].”
Background
Cited by
Oxidative stress and epigenetic modifications in the pathogenesis of diabetic retinopathy
Kowluru, R. A., Kowluru, A., Mishra, M., & Kumar, B. (2015) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2015.05.001 · Cited by 333
Epigenetic Modification of Mitochondrial DNA in the Development of Diabetic Retinopathy
Mishra, M., & Kowluru, R. A. (2015) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.15-16937 · Cited by 159
Increased global placental DNA methylation levels are associated with gestational diabetes
Reichetzeder, C., Dwi Putra, S. E., Pfab, T., Slowinski, T., Neuber, C., Kleuser, B., & Hocher, B. (2016) · Clinical Epigenetics · doi:10.1186/s13148-016-0247-9 · Cited by 144
Air pollution during pregnancy and placental adaptation in the levels of global DNA methylation
Maghbooli, Z., Hossein-nezhad, A., Adabi, E., Asadollah-pour, E., Sadeghi, M., Mohammad-nabi, S., Zakeri Rad, L., Malek Hosseini, A.-A., Radmehr, M., Faghihi, F., et al. (2018) · PLOS ONE · doi:10.1371/journal.pone.0199772 · Cited by 113
Self-citationInsights into the molecular underpinning of type 2 diabetes complications
Singh, A., Bocher, O., & Zeggini, E. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddae203 · Cited by 10
“Global DNA methylation changes have been foundto be predictive of DR and its progression, independently of classical risk factors, underscoring their role in disease pathogenesis [58].”
Metadata
- Authors
- Maghbooli, Z., Hossein‐nezhad, A., Larijani, B., Amini, M., & Keshtkar, A.
- Venue
- Diabetes/Metabolism Research and Reviews
- Publisher
- Wiley
- Published
- 2014-09-15
- Volume
- 31
- Issue
- 2
- Pages
- 183-189
- ISSN
- 1520-7552 (ISSN-L)
- 1520-7560
- OpenAlex
- W2121488055
- Cited by
- 97
- References
- 7
- FWCI
- 2.56
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.